Sunday, August 15, 2010

For The First Time, FDA-Approved Anti-Cancer Drugs May Not be Covered by Medicare

I think conservative critics of ObamaCare all deserve and apology from the supporters. This is the fear an criticism of the plan, fears which were brushed aside and labeled 'propaganda', coming true.

http://directorblue.blogspot.com/2010/08/berwicks-first-strike-susan-g-komen.html

"Just days after the recess appointment of Donald Berwick, the controversial new head of Medicare and Medicaid, the Ovarian Cancer National Alliance posted the following grim news: for the first time in history, an FDA-approved anti-cancer therapy may not be covered by Medicare.

Provenge, a vaccine to treat the recurrence of prostate cancer, has been approved by the Food and Drug Administration (FDA)... Medicare usually covers the cost of FDA-approved anti-cancer therapies. However, the Centers for Medicare and Medicaid Services (CMS) is still reviewing whether it will cover Provenge, and at what rate.

The CMS statute states that Medicare must cover therapies that are reasonable and necessary, while the FDA is instructed to approve drugs that are safe and effective. Because of the conflicting Federal coverage and approval requirements, there are some non-FDA approved drugs (called off-label drugs) that are paid for by CMS. However, with respect to Provenge, it appears that CMS is arguing that while the treatment is safe and effective, it may not be reasonable and necessary. For the first time, an FDA approved anti-cancer therapy may not be covered by Medicare.


A life-saving cancer treatment "may not be reasonable and necessary"? Gee, that kind of decision-making by an unelected federal bureaucracy certainly sounds like a death panel to me.

Say, I thought the President said that pre-existing conditions would always be covered. Isn't cancer a pre-existing condition?
"

No comments:

Post a Comment

Post a Comment

Related Posts with Thumbnails

Like what you read; Subscribe/Fan/Follow